Counting the cost of caplacizumab

Shruti Chaturvedi

doi:10.1182/blood.2020009250

Counting the cost of caplacizumab

School of Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	871-872
Number of pages	2
Journal	Blood
Volume	137
Issue number	7
DOIs	https://doi.org/10.1182/blood.2020009250
State	Published - Feb 18 2021

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2020009250

Cite this

@article{b233b9e5706047a6b7a3e48d9ed6b2dd,

title = "Counting the cost of caplacizumab",

author = "Shruti Chaturvedi",

year = "2021",

month = feb,

day = "18",

doi = "10.1182/blood.2020009250",

language = "English (US)",

volume = "137",

pages = "871--872",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "7",

}

TY - JOUR

T1 - Counting the cost of caplacizumab

AU - Chaturvedi, Shruti

PY - 2021/2/18

Y1 - 2021/2/18

UR - http://www.scopus.com/inward/record.url?scp=85100876343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85100876343&partnerID=8YFLogxK

U2 - 10.1182/blood.2020009250

DO - 10.1182/blood.2020009250

M3 - Editorial

C2 - 33599760

AN - SCOPUS:85100876343

SN - 0006-4971

VL - 137

SP - 871

EP - 872

JO - Blood

JF - Blood

IS - 7

ER -

Counting the cost of caplacizumab

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this